Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shih-Chi Ku

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Chest|January 1, 2025
Effect of Flow Rates of High-Flow Nasal Cannula on Extubation Outcomes: A Randomized Controlled TrialSheng-Yuan Ruan, Yao-Wen Kuo, Chun-Ta Huang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 11, 2023
Automatic tube compensation for liberation from prolonged mechanical ventilation in tracheostomized patients: A retrospective analysisChia-Hao Wu, Feng-Ching Lin, Jih-Shuin Jerng, et al.
International Journal of Antimicrobial Agents|December 6, 2021
Clinical effectiveness of cefoperazone-sulbactam vs. piperacillin-tazobactam for the treatment of pneumonia in elderly patientsChun-Ta Huang, Chia-Hung Chen, Wei-Chih Chen, et al.
Plos One|May 26, 2012
Concomitant pulmonary tuberculosis in hospitalized healthcare-associated pneumonia in a tuberculosis endemic area: a multi-center retrospective studyJia-Yih Feng, Wen-Feng Fang, Chieh-Liang Wu, et al.
Journal of Infection and Public Health|August 5, 2022
Clinical effectiveness of branded versus generic piperacillin-tazobactam for treating severe community-acquired pneumoniaCheng-Yi Wang, Chia-Hung Chen, Chih-Yen Tu, et al.
Nutrients|January 11, 2022
Significance of the Modified NUTRIC Score for Predicting Clinical Outcomes in Patients with Severe Community-Acquired PneumoniaChia-Cheng Tseng, Chih-Yen Tu, Chia-Hung Chen, et al.
Medicine|July 14, 2023
The clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of severe community-acquired pneumoniaChih-Cheng Lai, Wei-Chih Chen, Li-Kuo Kuo, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 12, 2021
Risk factors and prognosis assessment for acute kidney injury: The 2020 consensus of the Taiwan AKI Task ForceJia-Jin Chen, George Kuo, Chi-Chih Hung, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 22, 2013
Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in TaiwanChieh-Liang Wu, Shih-Chi Ku, Kuang-Yao Yang, et al.
Frontiers in Medicine|June 24, 2021
Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case ReportThomas Tao-Min Huang, Ying-Chun Chien, Chih-Hsien Wang, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Chest|January 1, 2025
Effect of Flow Rates of High-Flow Nasal Cannula on Extubation Outcomes: A Randomized Controlled TrialSheng-Yuan Ruan, Yao-Wen Kuo, Chun-Ta Huang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 11, 2023
Automatic tube compensation for liberation from prolonged mechanical ventilation in tracheostomized patients: A retrospective analysisChia-Hao Wu, Feng-Ching Lin, Jih-Shuin Jerng, et al.
International Journal of Antimicrobial Agents|December 6, 2021
Clinical effectiveness of cefoperazone-sulbactam vs. piperacillin-tazobactam for the treatment of pneumonia in elderly patientsChun-Ta Huang, Chia-Hung Chen, Wei-Chih Chen, et al.
Plos One|May 26, 2012
Concomitant pulmonary tuberculosis in hospitalized healthcare-associated pneumonia in a tuberculosis endemic area: a multi-center retrospective studyJia-Yih Feng, Wen-Feng Fang, Chieh-Liang Wu, et al.
Journal of Infection and Public Health|August 5, 2022
Clinical effectiveness of branded versus generic piperacillin-tazobactam for treating severe community-acquired pneumoniaCheng-Yi Wang, Chia-Hung Chen, Chih-Yen Tu, et al.
Nutrients|January 11, 2022
Significance of the Modified NUTRIC Score for Predicting Clinical Outcomes in Patients with Severe Community-Acquired PneumoniaChia-Cheng Tseng, Chih-Yen Tu, Chia-Hung Chen, et al.
Medicine|July 14, 2023
The clinical efficacy of cefoperazone-sulbactam versus piperacillin-tazobactam in the treatment of severe community-acquired pneumoniaChih-Cheng Lai, Wei-Chih Chen, Li-Kuo Kuo, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 12, 2021
Risk factors and prognosis assessment for acute kidney injury: The 2020 consensus of the Taiwan AKI Task ForceJia-Jin Chen, George Kuo, Chi-Chih Hung, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 22, 2013
Antimicrobial drug-resistant microbes associated with hospitalized community-acquired and healthcare-associated pneumonia: a multi-center study in TaiwanChieh-Liang Wu, Shih-Chi Ku, Kuang-Yao Yang, et al.
Frontiers in Medicine|June 24, 2021
Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case ReportThomas Tao-Min Huang, Ying-Chun Chien, Chih-Hsien Wang, et al.
Pageof 7